Preventive and Therapeutic Effect of Metformin in Head and Neck Cancer: A Concise Review.

Cyril BoulandXavier Vanden EyndenMartin LalmandThibaut BusetAntoine YanniRokneddine JavadianAlexandra RodriguezIsabelle LoebJérôme René Lechien Fabrice Journe Sven Saussez Didier Dequanter

Published in: Journal of clinical medicine (2023)

In conclusion, the results of this systematic review suggest that HNC patients may benefit from metformin. Indeed, it would reduce the HNC incidence. However, more studies are required to evaluate the effect on cancer-related survival rates.

Keyphrases

systematic review
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
meta analyses
risk factors
case control
free survival
patient reported